Alcon Inc. (ALCN)
BMV
Closed
Oct 6, 2026
Day's Range
1,195.5952 wk Range
1,158.62Overview - ALCN - Alcon Inc.
Key Statistics
Valuation
Enterprise Value
10.29T
P/E (Trailing)
‪51.55‬
PEG Ratio
‪-0.51‬
Price / Sales (TTM)
‪53.21‬
Price / Book
‪1.50‬
EV / EBITDA
‪242.01‬
Profitability
Gross Margin
‪59.33%‬
Profit Margin
‪5.92%‬
Operating Margin
‪14.63%‬
Return on Assets
‪2.79%‬
Return on Equity
‪2.94%‬
Ownership
Shares Outstanding
483.40M
Float
481.82M
Held by Insiders
‪0.19%‬
Held by Institutions
‪63.74%‬
Price stats
Beta
‪0.69‬
50-Day Avg
‪1,194.85‬
200-Day Avg
‪1,317.09‬
Dividends
Payout Ratio
‪27.03%‬
Frequency
Annual
Market Cap - ALCN - Alcon Inc.
Peers - ALCN - Alcon Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on BMV.
- ALALCNBMVAlcon Inc.577.94BMarket Cap-24.82%52-week change51.56P/E (Trailing)‪5.92%‬Profit Margin
- ISRGBMVIntuitive Surgical Inc.2.55TMarket Cap-13.48%52-week change47.19P/E (Trailing)‪28.44%‬Profit Margin
- ELUNBMVEssilorLuxottica1.50TMarket Cap-84.21%52-week change29.28P/E (Trailing)‪8.51%‬Profit Margin
- DGENBMVDiageo plc1.17TMarket Cap+0.00%52-week change26.45P/E (Trailing)‪8.84%‬Profit Margin
- 7741NBMVHOYA Corporation823.57BMarket Cap+9.53%52-week change28.65P/E (Trailing)‪27.17%‬Profit Margin
- STMNBMVSTMicroelectronics N.V.735.94BMarket Cap+39.76%52-week change107.51P/E (Trailing)‪3.55%‬Profit Margin
- BDXBMVBecton, Dickinson and Company731.03BMarket Cap-26.29%52-week change26.18P/E (Trailing)‪4.19%‬Profit Margin
Profile Summary - ALCN - Alcon Inc.
About
Alcon Inc. is a global eye care company focused on products and technologies that support vision health across surgical and everyday care settings. Alcon Inc. develops, manufactures, and markets a broad portfolio for cataract surgery, vitreoretinal procedures, glaucoma care, refractive surgery, contact lenses, lens…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
